Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDAGet Free Report) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Down 1.2 %

NASDAQ RKDA opened at $5.01 on Friday. The firm has a market cap of $6.81 million, a P/E ratio of -1.17 and a beta of 0.90. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The business’s 50-day moving average price is $4.80 and its 200 day moving average price is $3.67.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Featured Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.